Structural and functional characterization of recombinant human growth hormone isolated from transgenic pig milk
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- PLOS ONE15(7) · 2020
- 피인용
- Web of Science 1Scopus 1
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 2.74
- ISSN
- 1932-6203
저자
- Lee, So-Young제1저자교신저자CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- 한주희Department of Animal Science, College of Natural Resources and Life Science, Pusan National University, Miryang-si, Gyeongsangnam-do, Korea
- Lee, Eun-KyeongCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Kim, Young KyuCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Hwang, Seo-AhCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Lee, Sung-HyunCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Kim, MariaCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Cho, Gye YoonCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Hwang, Jae-HaCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Kim, Su-JinCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Yoo, Jae-GyuAnimal Diseases and Biosecurity Team, National Institute of Animal Science, Rural Development Administration, Wanju-gun, Jeollabuk-do, Korea
- 조성근Department of Animal Science, College of Natural Resources and Life Science, Pusan National University, Miryang-si, Gyeongsangnam-do, Korea
- Lee, Kyung-JuCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Cho, Weon-KiCHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
초록
This study aimed to establish and reproduce transgenic pigs expressing human growth hormone (hGH) in their milk. We also aimed to purify hGH from the milk, to characterize the purified protein, and to assess the potential of our model for mass production of therapeutic proteins using transgenic techniques. Using similar to 15.5 L transgenic pig milk, we obtained proteins with >= 99% purity after three pre-treatments and five column chromatography steps. To confirm the biosimilarity of our milk-derived purified recombinant hGH (CGH942) with commercially available somatropin (Genotropin), we performed spectroscopy, structural, and biological analyses. We observed no difference between the purified protein and Genotropin samples. Furthermore, rat models were used to assess growth promotion potential. Our results indicate that CGH942 promotes growth, by increasing bone development and body weight. Toxicity assessments revealed no abnormal findings after 4 weeks of continuous administration and 2 weeks of recovery. The no-observed-adverse-effect level for both males and females was determined to be 0.6 mg/kg/day. Thus, no toxicological differences were observed between commercially available somatropin and CGH942 obtained from transgenic pig milk. In conclusion, we describe a transgenic technique using pigs, providing a new platform to produce human therapeutic proteins.
키워드
HIGH-LEVEL EXPRESSIONESCHERICHIA-COLIPORCINE OOCYTESIN-VITROPROTEINPURIFICATIONDIMERIZATIONSECRETIONCOLOSTRUMCASEINS
식별자
- Scopus EID
- 2-s2.0-85089124950
- WoS UID
- 000569367100045



로그인
연구물 목록으로